维普期刊资源整合服务平台（V6.5）

37篇 您的检索式：作者名="RIDKERPM"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Inflammation atherosclerosis显示文摘	LibbyP RidkerPM	2002	Circulation2002，105，：	1
2	High - senusitivity C - reactive protein Potenitial adjunct for global risk assessment the prinary prevention of cardiovascular disease 显示文摘	RidkerPM	2001	Circulationg2001，103，13：	1
3	Proposed cardiovascular risk assessment algorithm using high sensitivity creative protein in and lipid screening显示文摘	Rifai N RidkerPM	2001	Clin Chem2001，47，1：	1
4	Fibrinolytic and inflammatory markers for arterial occlu-sion The evolving epidemiology of thrombosis and hem ostasis显示文摘	RidkerPM	1997	Th-romb Haemost1997，78，1：	1
5	Cliniealuse ofhigh - sensitivityC - reactive protein for the prediction ofadverse cardiovascular events 显示文摘	Tortes JL RidkerPM	2003	Curt Opin Cardiol2003，18，：	1
6	Efficacyofrosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER trial显示文摘	RidkerPM MacfadyenJ CressmanM etal	2010	J Am Coil Cardiol2010，55，1：	1
7	C-reactive protein and the prediction of cardiovascular events among those at intermediate risk显示文摘	RidkerPM	2007	J A m Coil Cardiol2007，49，21：	1
8	Plasmaconcentrationofsolubleintercellularadhesion-molecule1andrisksoffuturemyocardialinfarctioninapparentlyhealthy-men显示文摘	RidkerPM HennekensCH Roitman-JohnsonB etal	1998	Lancet1998，351，9096：	1
9	Inflammatorybio-markers and cardiovascular risk prediction显示文摘	BLAKEGJ RIDKERPM	2002	J Intern Med2002，252，：	1
10	Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial显示文摘	RidkerPM DanielsonE FonsecaFA	2009	Lancet2009，373，11：	1
11	Creactive protein and other markers of inflammation in the prediction of cardiovascular disease in women显示文摘	RidkerPM HennekensCH BuringJE etal	2000	New EngIJMed2000，342，12：	1
12	Relationship of lipoprotein-associated phospholipase A(2)mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial显示文摘	RidkerPM MacFadyenJG WolfertRL	2012	Clin Chem2012，58，87：	1
13	Comparison of Characteristics of Future Myocardial Infarctions in Women With Baseline High Versus Baseline Low Levels of High-Sensitivity C-Reactive Protein显示文摘	BansalS RidkerPM	2007	Am J Cardiol2007，99，11：	1
14	Inflammation,aspidn and risk of cardiovascular disease in apparently health men显示文摘	RidkerPM CushmanM StampferMJ	1997	N Engl J Med1997，336，14：	1
15	Prospective study of Creactive protein and the risk of future cardiovas- cular events among apparently heaIth women显示文摘	RidkerPM BuringJE MatiasM	1998	Circulation1998，98，：	1
16	C-reactive protein and the prediction of cardiovacular events among those at intermediate risk:moving an inflammatory hypothesis toward consensus显示文摘	RidkerPM	2007	J Am Coll Cardiol2007，49，21：	1
17	Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial 显示文摘	RidkerPM PradhanA MacFadyenJG etal	2012	Lancet2012，380，9841：	1
18	High-sensitivityC-reactiveprotein:clinicalimportance显示文摘	BassukSS RifaiN RidkerPM	2004	CurrProblCardiol2004，29，8：	1
19	Inflammation,aspi2 rin,andtheriskofcardiovasculardiseaseinapparentlyhealthymen显示文摘	RidkerPM CushmanM StampferMJ etal	1997	NenglJMed1997，36，：	1
20	C-reactiveprotein andothermarkersofinflammationinthepredictionofcardiovascu2 lardiseaseinwomen显示文摘	RidkerPM HennekensCH BuringJE etal	2000	NenglJMed2000，342，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示